Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index |
| |
Authors: | Jan Poleszczuk Rachel Walker Eduardo G. Moros Kujtim Latifi Jimmy J. Caudell Heiko Enderling |
| |
Affiliation: | 1.Department of Integrated Mathematical Oncology,H. Lee Moffitt Cancer Center and Research Institute,Tampa,USA;2.Department of Radiation Oncology,H. Lee Moffitt Cancer Center and Research Institute,Tampa,USA;3.Nalecz Institute of Biocybernetics and Biomedical Engineering,Polish Academy of Sciences,Warsaw,Poland |
| |
Abstract: | Radiation is commonly used in cancer treatment. Over 50% of all cancer patients will undergo radiotherapy (RT) as part of cancer care. Scientific advances in RT have primarily focused on the physical characteristics of treatment including beam quality and delivery. Only recently have inroads been made into utilizing tumor biology and radiobiology to design more appropriate RT protocols. Tumors are composites of proliferating and growth-arrested cells, and overall response depends on their respective proportions at irradiation. Prokopiou et al. (Radiat Oncol 10:159, 2015) developed the concept of the proliferation saturation index (PSI) to augment the clinical decision process associated with RT. This framework is based on the application of the logistic equation to pre-treatment imaging data in order to estimate a patient-specific tumor carrying capacity, which is then used to recommend a specific RT protocol. It is unclear, however, how dependent clinical recommendations are on the underlying tumor growth law. We discuss a PSI framework with a generalized logistic equation that can capture kinetics of different well-known growth laws including logistic and Gompertzian growth. Estimation of model parameters on the basis of clinical data revealed that the generalized logistic model can describe data equally well for a wide range of the generalized logistic exponent value. Clinical recommendations based on the calculated PSI, however, are strongly dependent on the specific growth law assumed. Our analysis suggests that the PSI framework may best be utilized in clinical practice when the underlying tumor growth law is known, or when sufficiently many tumor growth models suggest similar fractionation protocols. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|